Activated protein C resistance in cord blood from healthy and complicated newborns

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 20, Issue 11, 2007, Pages 797-801

  Gursel, Turkiz ^a,b   Kocak, Ulker ^a   Kaya, Zuhre ^a   Bukulmez, Aysegul ^a   Atalay, Yildiz ^a  

^a GAZI UNIVERSITY FACULTY OF MEDICINE   (Turkey)

^b NONE   (Turkey)

Author keywords

Activated protein C resistance; Cord blood

Indexed keywords

ANTITHROMBIN III; PROTEIN C; PROTEIN S;

ACTIVATED PROTEIN C RESISTANCE; ARTICLE; CESAREAN SECTION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; NEWBORN; PERINATAL ASPHYXIA; PREECLAMPSIA; PREMATURITY; PRIORITY JOURNAL; UMBILICAL CORD BLOOD; VAGINAL DELIVERY; VENOUS BLOOD;

ACTIVATED PROTEIN C RESISTANCE; ADOLESCENT; ADULT; ANTITHROMBIN III; ASPHYXIA NEONATORUM; CASE-CONTROL STUDIES; FEMALE; FETAL BLOOD; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; PRE-ECLAMPSIA; PREGNANCY; PROTEIN C; PROTEIN S; THROMBOSIS;

EID: 35448954908     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.1080/14767050701500299     Document Type: Article

References (24)

1. Nowak-Göttl U, Kosch A, Schlegel N. Thromboembolism in newborns infants and children. Thromb Haemost 2001;86:464-474.
2. Nowak-Göttl U, Kosch A, Schlegel N, Salem M, Manco-Johnson M. Thromboembolism in children. Curr Opin Hematol 2002;9:448-453.
3. Nowak-Göttl U, von Kries R, Gobel U. Neonatal symptomatic thromboembolism in Germany: Two year survey. Arch Dis Child Fetal Neonatal Ed 1997;76:163-167.
4. Andrew M, Paes B, Johnston M. Development of the hemostatic system in the neonate and young infant. Am J Pediatr Hematol Oncol 1990;12:95-104.
5. Reverdiau-Moalic P, Delahousse B, Body G, Bardos P, Leroy J, Gruel Y. Evolution of blood coagulation activators and inhibitors in the healthy human fetus. Blood 1996;88:900-906.
6. Schmidt B, Andrew M. Neonatal thrombosis: Report of a prospective Canadian and international registry. Pediatrics 1995;96:939-943.
7. Nowak-Gottl U, Koch HG, Aschka I, Kohlhase B, Vielhaber H, Kurlemann G, Oleszcuk-Raschke K, Kehl HG, Jurgens H, Schneppenheim R. Resistance to activated protein C (APCR) in children with venous or arterial thromboembolism. Br J Haematol 1996;92:992-998.
8. Dahlback B. Activated protein C resistance and thrombosis. Molecular mechanisms of hypercoagulable state due to FVR506Q mutation. Semin Thromb Haemost 1999;25:273-289.
9. Rodeghiero F, Tosetto A. Activated protein C resistance and factor V Leiden mutation are independent risk factors for venous thromboembolism. Ann Intern Med 1999;130:643-650.
10. Hellgren M, Svensson PJ, Dahlback B. Resistance to activated protein C as a basis for venous thromboembolism associated with pregnancy and oral contraceptives. Am J Obstet Gynecol 1995;173:210-213.
11. Paternoster DM, Stella A, Simioni P, Girolami A, Snijders D. Activated protein C resistance in normal and pre-eclamptic pregnancies. Gynecol Obstet Invest 2002;54:145-149.
12. Sifontes MT, Nuss R, Hunger SP, Jacobson LJ, Waters J, Manco-Johnson MJ. Correlation between the functional assay for activated protein C resistance and factor V Leiden in the neonate. Pediatr Res 1997;42:776-778.
13. Michiels JJ, Hamulyak K. Laboratory diagnosis of hereditary thrombophilia. Semin Thromb Haemost 1998;24:309-320.
14. Brandt G, Gruppo R, Glueck CJ, Stroop D, Becker A, Pillow A, Wang P. Sensitivity, specificity and predictive value of modified assays for activated protein C resistance in children. Thromb Haemost 1998;79:567-570.
15. Cvirn G, Gallistl S, Koestenberger M, Baier K, Fritsch P, Greilberger J, Jurgens G, Muntean W. The anticoagulant action of recombinant human activated protein C (rhAPC, Drotrecogin alpha activated): Comparison between cord and adult plasma. Thromb Haemost 2004;91:912-918.
16. Uttenreuther-Fischer MM, Ziemer S, Gaedicke G. Resistance to activated protein C (APCR): Reference values of APC-ratios for children. Thromb Haemost 1996;76:813-814.
17. Oger E, Leroyer C, Mercier B, Van Dreden P, Bressollette L, De Saint-Martin L, Le Moigne E, Blouch MT, Thuillier N, Amiral J, et al. Assessment of activated protein C resistance using a new and rapid venom-based test: STA Statclot APC-R. Blood Coagul Fibrinolysis 1998;9:355-359.
18. Lao TT, Yin JA, Yuen PM. Coagulation and anticoagulation systems in newborns - correlation with their mothers at delivery. Lower levels of anticoagulants and fibrinolytic activity in newborn. Gynecol Obstet Invest 1990;29:181-184.
19. Franzoi M, Simioni P, Luni S, Zerbinati P, Girolami A, Zanardo V. Effect of delivery modalities on the physiologic inhibition system of coagulation of the neonate. Thromb Research 2002;105:15-18.
20. Grandone E, Margaglione M, Colaizzo D, d'Addedda M, Cappucci G, Vecchione G, Scianname N, Pavone G, Di Minno G. Factor V Leiden is associated with repeated and recurrent unexplained fetal losses. Thromb Haemost 1997;77:822-824.
21. Hathaway WE, Mahasandana C, Makowski EL. Cord blood coagulation studies in infants of high risk pregnant women. Am J Obstet Gynecol 1975;121:51-57.
22. Tanjung MT, Siddik HD, Hariman H, Koh SC. Coagulation and fibrinolysis in preeclampsia and neonate. Clin Appl Thromb Haemost 2005;11:467-473.
23. Zanardo V, Savio V, Sabrina G, Franzoi M, Zerbinati P, Fadin M, Tognin G, Tormene D, Pagnan A, Simioni P. The effect of pre-eclampsia on the levels of coagulation and fibrinolysis factors in umbilical cord blood of newborns. Blood Coagul Fibrinolysis 2005;16:177-181.
24. de Ronde H, Bertina RM. Laboratory diagnosis of APC-resistance: A critical evaluation of the test and the development of diagnostic criteria. Thromb Haemost 1994;72:880-886.